Texas 2019 - 86th Regular

Texas Senate Bill SB1096 Latest Draft

Bill / Enrolled Version Filed 05/27/2019

                            S.B. No. 1096


 AN ACT
 relating to the Medicaid managed care program, including the
 provision of pharmacy benefits.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 533.00253, Government Code, is amended
 by adding Subsections (m) and (n) to read as follows:
 (m)  The advisory committee or a successor committee shall
 explore the feasibility of adopting a private duty nursing
 assessment for use in the STAR Kids managed care program and provide
 recommendations to the commission on adopting a private duty
 nursing assessment tool that would streamline the documentation for
 prior authorization of private duty nursing.  This subsection
 expires September 1, 2021.
 (n)  The commission, at least once every two years, shall
 conduct a utilization review on a sample of cases for children
 enrolled in the STAR Kids managed care program to ensure that all
 imposed clinical prior authorizations are based on publicly
 available clinical criteria and are not being used to negatively
 impact a recipient's access to care.
 SECTION 2.  Subchapter A, Chapter 533, Government Code, is
 amended by adding Section 533.002821 to read as follows:
 Sec. 533.002821.  PRIOR AUTHORIZATION PROCEDURES FOR
 HOSPITALIZED RECIPIENT.  In addition to the requirements of Section
 533.005, a contract between a managed care organization and the
 commission described by that section must require that,
 notwithstanding any other law, the organization review and issue
 determinations on prior authorization requests with respect to a
 recipient who is hospitalized at the time of the request according
 to the following time frames:
 (1)  within one business day after receiving the
 request, except as provided by Subdivisions (2) and (3);
 (2)  within 72 hours after receiving the request if the
 request is submitted by a provider of acute care inpatient services
 for services or equipment necessary to discharge the recipient from
 an inpatient facility; or
 (3)  within one hour after receiving the request if the
 request is related to poststabilization care or a life-threatening
 condition.
 SECTION 3.  Section 533.005, Government Code, is amended by
 amending Subsection (a) and adding Subsection (g) to read as
 follows:
 (a)  A contract between a managed care organization and the
 commission for the organization to provide health care services to
 recipients must contain:
 (1)  procedures to ensure accountability to the state
 for the provision of health care services, including procedures for
 financial reporting, quality assurance, utilization review, and
 assurance of contract and subcontract compliance;
 (2)  capitation rates that ensure the cost-effective
 provision of quality health care;
 (3)  a requirement that the managed care organization
 provide ready access to a person who assists recipients in
 resolving issues relating to enrollment, plan administration,
 education and training, access to services, and grievance
 procedures;
 (4)  a requirement that the managed care organization
 provide ready access to a person who assists providers in resolving
 issues relating to payment, plan administration, education and
 training, and grievance procedures;
 (5)  a requirement that the managed care organization
 provide information and referral about the availability of
 educational, social, and other community services that could
 benefit a recipient;
 (6)  procedures for recipient outreach and education;
 (7)  a requirement that the managed care organization
 make payment to a physician or provider for health care services
 rendered to a recipient under a managed care plan on any claim for
 payment that is received with documentation reasonably necessary
 for the managed care organization to process the claim:
 (A)  not later than:
 (i)  the 10th day after the date the claim is
 received if the claim relates to services provided by a nursing
 facility, intermediate care facility, or group home;
 (ii)  the 30th day after the date the claim
 is received if the claim relates to the provision of long-term
 services and supports not subject to Subparagraph (i); and
 (iii)  the 45th day after the date the claim
 is received if the claim is not subject to Subparagraph (i) or (ii);
 or
 (B)  within a period, not to exceed 60 days,
 specified by a written agreement between the physician or provider
 and the managed care organization;
 (7-a)  a requirement that the managed care organization
 demonstrate to the commission that the organization pays claims
 described by Subdivision (7)(A)(ii) on average not later than the
 21st day after the date the claim is received by the organization;
 (8)  a requirement that the commission, on the date of a
 recipient's enrollment in a managed care plan issued by the managed
 care organization, inform the organization of the recipient's
 Medicaid certification date;
 (9)  a requirement that the managed care organization
 comply with Section 533.006 as a condition of contract retention
 and renewal;
 (10)  a requirement that the managed care organization
 provide the information required by Section 533.012 and otherwise
 comply and cooperate with the commission's office of inspector
 general and the office of the attorney general;
 (11)  a requirement that the managed care
 organization's usages of out-of-network providers or groups of
 out-of-network providers may not exceed limits for those usages
 relating to total inpatient admissions, total outpatient services,
 and emergency room admissions determined by the commission;
 (12)  if the commission finds that a managed care
 organization has violated Subdivision (11), a requirement that the
 managed care organization reimburse an out-of-network provider for
 health care services at a rate that is equal to the allowable rate
 for those services, as determined under Sections 32.028 and
 32.0281, Human Resources Code;
 (13)  a requirement that, notwithstanding any other
 law, including Sections 843.312 and 1301.052, Insurance Code, the
 organization:
 (A)  use advanced practice registered nurses and
 physician assistants in addition to physicians as primary care
 providers to increase the availability of primary care providers in
 the organization's provider network; and
 (B)  treat advanced practice registered nurses
 and physician assistants in the same manner as primary care
 physicians with regard to:
 (i)  selection and assignment as primary
 care providers;
 (ii)  inclusion as primary care providers in
 the organization's provider network; and
 (iii)  inclusion as primary care providers
 in any provider network directory maintained by the organization;
 (14)  a requirement that the managed care organization
 reimburse a federally qualified health center or rural health
 clinic for health care services provided to a recipient outside of
 regular business hours, including on a weekend day or holiday, at a
 rate that is equal to the allowable rate for those services as
 determined under Section 32.028, Human Resources Code, if the
 recipient does not have a referral from the recipient's primary
 care physician;
 (15)  a requirement that the managed care organization
 develop, implement, and maintain a system for tracking and
 resolving all provider appeals related to claims payment, including
 a process that will require:
 (A)  a tracking mechanism to document the status
 and final disposition of each provider's claims payment appeal;
 (B)  the contracting with physicians who are not
 network providers and who are of the same or related specialty as
 the appealing physician to resolve claims disputes related to
 denial on the basis of medical necessity that remain unresolved
 subsequent to a provider appeal;
 (C)  the determination of the physician resolving
 the dispute to be binding on the managed care organization and
 provider; and
 (D)  the managed care organization to allow a
 provider with a claim that has not been paid before the time
 prescribed by Subdivision (7)(A)(ii) to initiate an appeal of that
 claim;
 (16)  a requirement that a medical director who is
 authorized to make medical necessity determinations is available to
 the region where the managed care organization provides health care
 services;
 (17)  a requirement that the managed care organization
 ensure that a medical director and patient care coordinators and
 provider and recipient support services personnel are located in
 the South Texas service region, if the managed care organization
 provides a managed care plan in that region;
 (18)  a requirement that the managed care organization
 provide special programs and materials for recipients with limited
 English proficiency or low literacy skills;
 (19)  a requirement that the managed care organization
 develop and establish a process for responding to provider appeals
 in the region where the organization provides health care services;
 (20)  a requirement that the managed care organization:
 (A)  develop and submit to the commission, before
 the organization begins to provide health care services to
 recipients, a comprehensive plan that describes how the
 organization's provider network complies with the provider access
 standards established under Section 533.0061;
 (B)  as a condition of contract retention and
 renewal:
 (i)  continue to comply with the provider
 access standards established under Section 533.0061; and
 (ii)  make substantial efforts, as
 determined by the commission, to mitigate or remedy any
 noncompliance with the provider access standards established under
 Section 533.0061;
 (C)  pay liquidated damages for each failure, as
 determined by the commission, to comply with the provider access
 standards established under Section 533.0061 in amounts that are
 reasonably related to the noncompliance; and
 (D)  regularly, as determined by the commission,
 submit to the commission and make available to the public a report
 containing data on the sufficiency of the organization's provider
 network with regard to providing the care and services described
 under Section 533.0061(a) and specific data with respect to access
 to primary care, specialty care, long-term services and supports,
 nursing services, and therapy services on the average length of
 time between:
 (i)  the date a provider requests prior
 authorization for the care or service and the date the organization
 approves or denies the request; and
 (ii)  the date the organization approves a
 request for prior authorization for the care or service and the date
 the care or service is initiated;
 (21)  a requirement that the managed care organization
 demonstrate to the commission, before the organization begins to
 provide health care services to recipients, that, subject to the
 provider access standards established under Section 533.0061:
 (A)  the organization's provider network has the
 capacity to serve the number of recipients expected to enroll in a
 managed care plan offered by the organization;
 (B)  the organization's provider network
 includes:
 (i)  a sufficient number of primary care
 providers;
 (ii)  a sufficient variety of provider
 types;
 (iii)  a sufficient number of providers of
 long-term services and supports and specialty pediatric care
 providers of home and community-based services; and
 (iv)  providers located throughout the
 region where the organization will provide health care services;
 and
 (C)  health care services will be accessible to
 recipients through the organization's provider network to a
 comparable extent that health care services would be available to
 recipients under a fee-for-service or primary care case management
 model of Medicaid managed care;
 (22)  a requirement that the managed care organization
 develop a monitoring program for measuring the quality of the
 health care services provided by the organization's provider
 network that:
 (A)  incorporates the National Committee for
 Quality Assurance's Healthcare Effectiveness Data and Information
 Set (HEDIS) measures or, as applicable, the national core
 indicators adult consumer survey and the national core indicators
 child family survey for individuals with an intellectual or
 developmental disability;
 (B)  focuses on measuring outcomes; and
 (C)  includes the collection and analysis of
 clinical data relating to prenatal care, preventive care, mental
 health care, and the treatment of acute and chronic health
 conditions and substance abuse;
 (23)  subject to Subsection (a-1), a requirement that
 the managed care organization develop, implement, and maintain an
 outpatient pharmacy benefit plan for its enrolled recipients:
 (A)  that, except as provided by Paragraph
 (L)(ii), exclusively employs the vendor drug program formulary and
 preserves the state's ability to reduce waste, fraud, and abuse
 under Medicaid;
 (B)  that adheres to the applicable preferred drug
 list adopted by the commission under Section 531.072;
 (C)  that, except as provided by Paragraph (L)(i),
 includes the prior authorization procedures and requirements
 prescribed by or implemented under Sections 531.073(b), (c), and
 (g) for the vendor drug program;
 (D)  for purposes of which the managed care
 organization:
 (i)  may not negotiate or collect rebates
 associated with pharmacy products on the vendor drug program
 formulary; and
 (ii)  may not receive drug rebate or pricing
 information that is confidential under Section 531.071;
 (E)  that complies with the prohibition under
 Section 531.089;
 (F)  under which the managed care organization may
 not prohibit, limit, or interfere with a recipient's selection of a
 pharmacy or pharmacist of the recipient's choice for the provision
 of pharmaceutical services under the plan through the imposition of
 different copayments;
 (G)  that allows the managed care organization or
 any subcontracted pharmacy benefit manager to contract with a
 pharmacist or pharmacy providers separately for specialty pharmacy
 services, except that:
 (i)  the managed care organization and
 pharmacy benefit manager are prohibited from allowing exclusive
 contracts with a specialty pharmacy owned wholly or partly by the
 pharmacy benefit manager responsible for the administration of the
 pharmacy benefit program; and
 (ii)  the managed care organization and
 pharmacy benefit manager must adopt policies and procedures for
 reclassifying prescription drugs from retail to specialty drugs,
 and those policies and procedures must be consistent with rules
 adopted by the executive commissioner and include notice to network
 pharmacy providers from the managed care organization;
 (H)  under which the managed care organization may
 not prevent a pharmacy or pharmacist from participating as a
 provider if the pharmacy or pharmacist agrees to comply with the
 financial terms and conditions of the contract as well as other
 reasonable administrative and professional terms and conditions of
 the contract;
 (I)  under which the managed care organization may
 include mail-order pharmacies in its networks, but may not require
 enrolled recipients to use those pharmacies, and may not charge an
 enrolled recipient who opts to use this service a fee, including
 postage and handling fees;
 (J)  under which the managed care organization or
 pharmacy benefit manager, as applicable, must pay claims in
 accordance with Section 843.339, Insurance Code; [and]
 (K)  under which the managed care organization or
 pharmacy benefit manager, as applicable:
 (i)  to place a drug on a maximum allowable
 cost list, must ensure that:
 (a)  the drug is listed as "A" or "B"
 rated in the most recent version of the United States Food and Drug
 Administration's Approved Drug Products with Therapeutic
 Equivalence Evaluations, also known as the Orange Book, has an "NR"
 or "NA" rating or a similar rating by a nationally recognized
 reference; and
 (b)  the drug is generally available
 for purchase by pharmacies in the state from national or regional
 wholesalers and is not obsolete;
 (ii)  must provide to a network pharmacy
 provider, at the time a contract is entered into or renewed with the
 network pharmacy provider, the sources used to determine the
 maximum allowable cost pricing for the maximum allowable cost list
 specific to that provider;
 (iii)  must review and update maximum
 allowable cost price information at least once every seven days to
 reflect any modification of maximum allowable cost pricing;
 (iv)  must, in formulating the maximum
 allowable cost price for a drug, use only the price of the drug and
 drugs listed as therapeutically equivalent in the most recent
 version of the United States Food and Drug Administration's
 Approved Drug Products with Therapeutic Equivalence Evaluations,
 also known as the Orange Book;
 (v)  must establish a process for
 eliminating products from the maximum allowable cost list or
 modifying maximum allowable cost prices in a timely manner to
 remain consistent with pricing changes and product availability in
 the marketplace;
 (vi)  must:
 (a)  provide a procedure under which a
 network pharmacy provider may challenge a listed maximum allowable
 cost price for a drug;
 (b)  respond to a challenge not later
 than the 15th day after the date the challenge is made;
 (c)  if the challenge is successful,
 make an adjustment in the drug price effective on the date the
 challenge is resolved[,] and make the adjustment applicable to all
 similarly situated network pharmacy providers, as determined by the
 managed care organization or pharmacy benefit manager, as
 appropriate;
 (d)  if the challenge is denied,
 provide the reason for the denial; and
 (e)  report to the commission every 90
 days the total number of challenges that were made and denied in the
 preceding 90-day period for each maximum allowable cost list drug
 for which a challenge was denied during the period;
 (vii)  must notify the commission not later
 than the 21st day after implementing a practice of using a maximum
 allowable cost list for drugs dispensed at retail but not by mail;
 and
 (viii)  must provide a process for each of
 its network pharmacy providers to readily access the maximum
 allowable cost list specific to that provider; and
 (L)  under which the managed care organization or
 pharmacy benefit manager, as applicable:
 (i)  may not require a prior authorization,
 other than a clinical prior authorization or a prior authorization
 imposed by the commission to minimize the opportunity for waste,
 fraud, or abuse, for or impose any other barriers to a drug that is
 prescribed to a child enrolled in the STAR Kids managed care program
 for a particular disease or treatment and that is on the vendor drug
 program formulary or require additional prior authorization for a
 drug included in the preferred drug list adopted under Section
 531.072;
 (ii)  must provide for continued access to a
 drug prescribed to a child enrolled in the STAR Kids managed care
 program, regardless of whether the drug is on the vendor drug
 program formulary or, if applicable on or after August 31, 2023, the
 managed care organization's formulary;
 (iii)  may not use a protocol that requires a
 child enrolled in the STAR Kids managed care program to use a
 prescription drug or sequence of prescription drugs other than the
 drug that the child's physician recommends for the child's
 treatment before the managed care organization provides coverage
 for the recommended drug; and
 (iv)  must pay liquidated damages to the
 commission for each failure, as determined by the commission, to
 comply with this paragraph in an amount that is a reasonable
 forecast of the damages caused by the noncompliance;
 (24)  a requirement that the managed care organization
 and any entity with which the managed care organization contracts
 for the performance of services under a managed care plan disclose,
 at no cost, to the commission and, on request, the office of the
 attorney general all discounts, incentives, rebates, fees, free
 goods, bundling arrangements, and other agreements affecting the
 net cost of goods or services provided under the plan;
 (25)  a requirement that the managed care organization
 not implement significant, nonnegotiated, across-the-board
 provider reimbursement rate reductions unless:
 (A)  subject to Subsection (a-3), the
 organization has the prior approval of the commission to make the
 reductions [reduction]; or
 (B)  the rate reductions are based on changes to
 the Medicaid fee schedule or cost containment initiatives
 implemented by the commission; and
 (26)  a requirement that the managed care organization
 make initial and subsequent primary care provider assignments and
 changes.
 (g)  The commission shall provide guidance and additional
 education to managed care organizations with which the commission
 enters into contracts described by Subsection (a) regarding
 requirements under federal law to continue to provide services
 during an internal appeal, a Medicaid fair hearing, or any other
 review.
 SECTION 4.  (a)  Section 533.002821, Government Code, as
 added by this Act, and Section 533.005, Government Code, as amended
 by this Act, apply only to a contract between the Health and Human
 Services Commission and a managed care organization under Chapter
 533, Government Code, that is entered into or renewed on or after
 the effective date of this Act.
 (b)  As soon as practicable after the effective date of this
 Act but not later than September 1, 2020, the Health and Human
 Services Commission shall seek to amend contracts entered into with
 managed care organizations under Chapter 533, Government Code,
 before the effective date of this Act to include the provisions
 required by Section 533.002821, Government Code, as added by this
 Act, and Section 533.005, Government Code, as amended by this Act.
 SECTION 5.  If before implementing any provision of this Act
 a state agency determines that a waiver or authorization from a
 federal agency is necessary for implementation of that provision,
 the agency affected by the provision shall request the waiver or
 authorization and may delay implementing that provision until the
 waiver or authorization is granted.
 SECTION 6.  The Health and Human Services Commission is
 required to implement a provision of this Act only if the
 legislature appropriates money specifically for that purpose.  If
 the legislature does not appropriate money specifically for that
 purpose, the commission may, but is not required to, implement a
 provision of this Act using other appropriations available for that
 purpose.
 SECTION 7.  This Act takes effect September 1, 2019.
 ______________________________ ______________________________
 President of the Senate Speaker of the House
 I hereby certify that S.B. No. 1096 passed the Senate on
 May 2, 2019, by the following vote:  Yeas 30, Nays 1; May 20, 2019,
 Senate refused to concur in House amendments and requested
 appointment of Conference Committee; May 22, 2019, House granted
 request of the Senate; May 26, 2019, Senate adopted Conference
 Committee Report by the following vote:  Yeas 30, Nays 1.
 ______________________________
 Secretary of the Senate
 I hereby certify that S.B. No. 1096 passed the House, with
 amendments, on May 17, 2019, by the following vote:  Yeas 136,
 Nays 10, one present not voting; May 22, 2019, House granted
 request of the Senate for appointment of Conference Committee;
 May 26, 2019, House adopted Conference Committee Report by the
 following vote:  Yeas 144, Nays 1, two present not voting.
 ______________________________
 Chief Clerk of the House
 Approved:
 ______________________________
 Date
 ______________________________
 Governor